State Street Corp Blueprint Medicines Corp Call Options Transaction History
State Street Corp
- $2.25 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BPMC
# of Institutions
345Shares Held
61.8MCall Options Held
1.2MPut Options Held
621K-
Vanguard Group Inc Valley Forge, PA6.68MShares$647 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$644 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.87MShares$569 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA3.24MShares$313 Million0.06% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.46MShares$238 Million8.22% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.79B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...